Mobileye shorts hit a year-high as analysts cut across the board

Short interest in MBLY jumped 12.5% in a single week to 23.4% of the free float, the highest level recorded in at least a year and a move that sits 2.1 standard deviations above the company's typical weekly swing, arriving the same day the stock fell 7% and posted a 15.6% single-session loss after its earnings release.

The positioning picture is dominated by that short-interest surge. Roughly 50.6 million shares are now borrowed against Mobileye, up from 44.4 million a week earlier, with the sharpest step-change coming overnight between October 23 and October 26. Cost to borrow has followed, nearly doubling on the week to 0.85%, its highest reading in the 30-day window, though it remains low in absolute terms, signalling this is a conviction trade rather than a scarcity-driven squeeze. Availability is still generous at 397%, meaning roughly four shares sit available in the lending pool for every one already borrowed, so the borrow market is not tight and there is no mechanical pressure forcing short sellers to cover. The ORTEX short score has climbed to 68.8, its highest reading of the past fortnight. Options, by contrast, are striking in their calm: the put/call ratio dropped to 0.48 on October 30, more than three standard deviations below its 20-day average of 0.52, the lowest defensive posture in the past year. That gap between aggressive short-side positioning and unusually light options hedging is the week's central tension.

Analyst reaction to the earnings print has been swift and largely one-directional. Goldman Sachs trimmed its target to $7 while holding Neutral, and TD Cowen went further, cutting both its target (to $7) and its rating, moving from Buy to Hold. Needham held its Buy but slashed the target to $9 from $13. RBC moved to Underperform with a $5 target as recently as October 21. The consensus now sits at Hold, with 7 buys against 11 holds and a mean target of $10.17, still 71% above the current $5.96 price. That gap looks wide on paper but should be read carefully: targets across the coverage have been moving consistently lower for weeks, and the direction of travel matters as much as the level. On valuation, the EV/EBITDA multiple has contracted nearly 0.9 turns in a single day to 7.0x, and the price-to-book has fallen to 0.64. The short score factor rank is in the 7th percentile of its universe, the lowest ranking in the factor set and a direct reflection of the short-side pressure that has built through October.

The structural debate about Mobileye has sharpened around earnings. The bear argument, that OEMs are migrating toward centralised compute architectures and shrinking the addressable content in Mobileye's roughly $1.9 billion base ADAS business, gained ammunition this week. The SuperVision and Chauffeur programmes remain heavily dependent on Volkswagen Group, and only two of the expected OEM wins have materialised nearly two years after the December 2024 investor day. The bull case rests on the higher-value Surround ADAS product averaging $150 to $200 per vehicle versus $40 to $50 for legacy systems, a $24.5 billion eight-year revenue pipeline, and robotaxi partnerships with Uber and Lyft that are still intact. Q2 2026 revenue was $508 million with a 46% gross margin and $135 million of operating cash flow, numbers that support the view that the core business has not broken, even if the growth trajectory has disappointed.

Ownership adds one notable layer. CEO Amnon Shashua filed a Schedule 13D in February 2026 disclosing a 7.3% stake, which places an activist-style filing on the register from Mobileye's own founder. That is not the same as an external activist seeking change, but it does register formally as a 13D rather than a passive 13G, a distinction worth carrying. Intel remains the dominant holder at 76% of shares, and its own position is the single largest variable in the stock's ownership story: any change in Intel's strategic posture toward its Mobileye stake would reconfigure the float entirely. Stakes are as last disclosed, and Intel's most recent filing was made in November 2025 reflecting an April figure of around 76%. Closer to the open market, two directors, Safroadu Yeboah-Amankwah and Frank Yeary, made open-market purchases in late July and early August at prices between $7.98 and $8.46, around 34% above the current level. The net insider balance over 90 days is a modest $198,808 of open-market buying, not a large number, but the direction is notable given the stock's trajectory.

Peers have also sold off on the week, with HSAI down 7.2% and WRD down 0.7%, so Mobileye's 8.9% weekly decline is not entirely company-specific. The next scheduled earnings event is January 21, 2027, leaving 82 days for the short-side thesis to be tested against order updates, design-win announcements, or any change in Intel's disclosed position.